These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17269899)

  • 21. Assessment of the health effects of chemicals in humans: I. QSAR estimation of the maximum recommended therapeutic dose (MRTD) and no effect level (NOEL) of organic chemicals based on clinical trial data.
    Matthews EJ; Kruhlak NL; Benz RD; Contrera JF
    Curr Drug Discov Technol; 2004 Jan; 1(1):61-76. PubMed ID: 16472220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines for developing and using quantitative structure-activity relationships.
    Walker JD; Jaworska J; Comber MH; Schultz TW; Dearden JC
    Environ Toxicol Chem; 2003 Aug; 22(8):1653-65. PubMed ID: 12924568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring QSARs with Extended Topochemical Atom (ETA) indices for modeling chemical and drug toxicity.
    Roy K; Ghosh G
    Curr Pharm Des; 2010; 16(24):2625-39. PubMed ID: 20642426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introduction to the EU REACH legislation.
    Grindon C; Combes R
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():1-6. PubMed ID: 19025328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro tests within the REACH information strategies.
    Louekari K; Sihvonen K; Kuittinen M; Sømnes V
    Altern Lab Anim; 2006 Aug; 34(4):377-86. PubMed ID: 16945005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehension of drug toxicity: software and databases.
    Toropov AA; Toropova AP; Raska I; Leszczynska D; Leszczynski J
    Comput Biol Med; 2014 Feb; 45():20-5. PubMed ID: 24480159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a quantitative structure-activity relationship for chronic narcosis to fish.
    Claeys L; Iaccino F; Janssen CR; Van Sprang P; Verdonck F
    Environ Toxicol Chem; 2013 Oct; 32(10):2217-25. PubMed ID: 23775559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promises and pitfalls of quantitative structure-activity relationship approaches for predicting metabolism and toxicity.
    Zvinavashe E; Murk AJ; Rietjens IM
    Chem Res Toxicol; 2008 Dec; 21(12):2229-36. PubMed ID: 19548346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of in vitro neurotoxicity testing for regulatory purposes: Symposium III summary and research needs.
    Bal-Price AK; Suñol C; Weiss DG; van Vliet E; Westerink RH; Costa LG
    Neurotoxicology; 2008 May; 29(3):520-31. PubMed ID: 18417220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. European Chemicals Agency dossier submissions as an experimental data source: refinement of a fish toxicity model for predicting acute LC50 values.
    Austin T; Denoyelle M; Chaudry A; Stradling S; Eadsforth C
    Environ Toxicol Chem; 2015 Feb; 34(2):369-78. PubMed ID: 25470737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated decision-tree testing strategies for environmental toxicity with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():29-42. PubMed ID: 19025330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In silico modeling for prediction of drug-induced adverse reactions and environmental hazards using QSAR tools.
    Saha A; Roy K
    Curr Drug Saf; 2012 Sep; 7(4):255-6. PubMed ID: 23278211
    [No Abstract]   [Full Text] [Related]  

  • 33. In Silico Models for Acute Systemic Toxicity.
    Burton J; Worth AP; Tsakovska I; Diukendjieva A
    Methods Mol Biol; 2016; 1425():177-200. PubMed ID: 27311468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relevance and Application of Read-Across - Mini Review of European Consensus Platform for Alternatives and Scandinavian Society for Cell Toxicology 2017 Workshop Session.
    Stuard SB; Heinonen T
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():37-41. PubMed ID: 29524304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated decision-tree testing strategies for acute systemic toxicity and toxicokinetics with respect to the requirements of the EU REACH legislation.
    Combes R; Grindon C; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Feb; 36(1):45-63. PubMed ID: 18333714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A three-tier QSAR modeling strategy for estimating eye irritation potential of diverse chemicals in rabbit for regulatory purposes.
    Basant N; Gupta S; Singh KP
    Regul Toxicol Pharmacol; 2016 Jun; 77():282-91. PubMed ID: 27018829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of QSARs in international decision-making frameworks to predict ecologic effects and environmental fate of chemical substances.
    Cronin MT; Walker JD; Jaworska JS; Comber MH; Watts CD; Worth AP
    Environ Health Perspect; 2003 Aug; 111(10):1376-90. PubMed ID: 12896861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. REACH and in silico methods: an attractive opportunity for medicinal chemists.
    Nicolotti O; Benfenati E; Carotti A; Gadaleta D; Gissi A; Mangiatordi GF; Novellino E
    Drug Discov Today; 2014 Nov; 19(11):1757-1768. PubMed ID: 24998783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-testing approaches under REACH--help or hindrance? Perspectives from a practitioner within industry.
    Patlewicz G; Chen MW; Bellin CA
    SAR QSAR Environ Res; 2011 Mar; 22(1-2):67-88. PubMed ID: 21391142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.